Figure 7 (IMAGE)

Impact Journals LLC

Figure 7

Caption

Mechanism of the antitumor activity of the RAD001 (everolimus) + volasertib combination.

Credit

Correspondence to - Didier Decaudin - Didier.decaudin@curie.fr

Usage Restrictions

Copyright: © 2021 Montaudon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.